HEADER TRANSCRIPTION 13-OCT-00 1G1U TITLE THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND TITLE 2 BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN (RESIDUES 225 - 462); COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET14 KEYWDS RXRALPHA LIGAND BINDING DOMAIN, TETRAMER, ABSENCE OF LIGAND, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,G.B.WISELY,M.V.MILBURN,H.E.XU REVDAT 4 16-OCT-24 1G1U 1 REMARK REVDAT 3 04-OCT-17 1G1U 1 REMARK REVDAT 2 24-FEB-09 1G1U 1 VERSN REVDAT 1 25-APR-01 1G1U 0 JRNL AUTH R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,G.B.WISELY, JRNL AUTH 2 M.V.MILBURN,H.E.XU JRNL TITL STRUCTURAL BASIS FOR AUTOREPRESSION OF RETINOID X RECEPTOR JRNL TITL 2 BY TETRAMER FORMATION AND THE AF-2 HELIX. JRNL REF GENES DEV. V. 14 2229 2000 JRNL REFN ISSN 0890-9369 JRNL PMID 10970886 JRNL DOI 10.1101/GAD.802300 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,A.B.MILLER, REMARK 1 AUTH 2 R.K.BLEDSOE,M.V.MILBURN,S.A.KLIEWER,T.M.WILLSON,H.E.XU REMARK 1 TITL ASYMMETRY IN THE PPARALPHA/RXRALPHA CRYSTAL STRUCTURE REMARK 1 TITL 2 REVEALS THE MOLECULAR BASIS OF HETERODIMERIZATION AMONG REMARK 1 TITL 3 NUCLEAR RECEPTORS REMARK 1 REF MOL.CELL V. 5 545 2000 REMARK 1 REFN ISSN 1097-2765 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 294297.550 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 32014 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3201 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4671 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 481 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6898 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.71000 REMARK 3 B22 (A**2) : -5.06000 REMARK 3 B33 (A**2) : 4.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.60000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 56.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BSXPI3.XPL REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G1U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1000012128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32492 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20MM HEPES PH 7.5, 1.5M LISO4, 10MM REMARK 280 DTT , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.65250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 225 REMARK 465 ALA A 226 REMARK 465 ASN A 227 REMARK 465 GLU A 228 REMARK 465 ASP A 229 REMARK 465 MET A 230 REMARK 465 HIS A 459 REMARK 465 GLN A 460 REMARK 465 MET A 461 REMARK 465 THR A 462 REMARK 465 SER B 225 REMARK 465 ALA B 226 REMARK 465 ASN B 227 REMARK 465 GLU B 228 REMARK 465 ASP B 229 REMARK 465 MET B 230 REMARK 465 GLN B 460 REMARK 465 MET B 461 REMARK 465 THR B 462 REMARK 465 SER C 225 REMARK 465 ALA C 226 REMARK 465 ASN C 227 REMARK 465 GLU C 228 REMARK 465 ASP C 229 REMARK 465 MET C 230 REMARK 465 ALA C 457 REMARK 465 PRO C 458 REMARK 465 HIS C 459 REMARK 465 GLN C 460 REMARK 465 MET C 461 REMARK 465 THR C 462 REMARK 465 SER D 225 REMARK 465 ALA D 226 REMARK 465 ASN D 227 REMARK 465 GLU D 228 REMARK 465 ASP D 229 REMARK 465 MET D 230 REMARK 465 GLN D 460 REMARK 465 MET D 461 REMARK 465 THR D 462 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 242 CG1 CG2 REMARK 470 GLU A 243 CG CD OE1 OE2 REMARK 470 PRO A 244 CG CD REMARK 470 LYS A 245 CG CD CE NZ REMARK 470 THR A 246 OG1 CG2 REMARK 470 GLU A 247 CG CD OE1 OE2 REMARK 470 THR A 248 OG1 CG2 REMARK 470 TYR A 249 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL A 250 CG1 CG2 REMARK 470 GLU A 251 CG CD OE1 OE2 REMARK 470 ASN A 253 CG OD1 ND2 REMARK 470 MET A 254 CG SD CE REMARK 470 LEU A 256 CG CD1 CD2 REMARK 470 ASN A 257 CG OD1 ND2 REMARK 470 PRO A 258 CG CD REMARK 470 SER A 259 OG REMARK 470 SER A 260 OG REMARK 470 PRO A 261 CG CD REMARK 470 ASN A 262 CG OD1 ND2 REMARK 470 ASP A 263 CG OD1 OD2 REMARK 470 PRO A 264 CG CD REMARK 470 VAL A 265 CG1 CG2 REMARK 470 GLN A 270 CG CD OE1 NE2 REMARK 470 PRO A 458 CG CD REMARK 470 VAL B 242 CG1 CG2 REMARK 470 GLU B 243 CG CD OE1 OE2 REMARK 470 PRO B 244 CG CD REMARK 470 LYS B 245 CG CD CE NZ REMARK 470 THR B 246 OG1 CG2 REMARK 470 GLU B 247 CG CD OE1 OE2 REMARK 470 THR B 248 OG1 CG2 REMARK 470 TYR B 249 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL B 250 CG1 CG2 REMARK 470 GLU B 251 CG CD OE1 OE2 REMARK 470 ASN B 253 CG OD1 ND2 REMARK 470 MET B 254 CG SD CE REMARK 470 LEU B 256 CG CD1 CD2 REMARK 470 ASN B 257 CG OD1 ND2 REMARK 470 PRO B 258 CG CD REMARK 470 SER B 259 OG REMARK 470 SER B 260 OG REMARK 470 PRO B 261 CG CD REMARK 470 ASN B 262 CG OD1 ND2 REMARK 470 ASP B 263 CG OD1 OD2 REMARK 470 HIS B 459 CG ND1 CD2 CE1 NE2 REMARK 470 GLU C 243 CG CD OE1 OE2 REMARK 470 PRO C 244 CG CD REMARK 470 LYS C 245 CG CD CE NZ REMARK 470 THR C 246 OG1 CG2 REMARK 470 GLU C 247 CG CD OE1 OE2 REMARK 470 THR C 248 OG1 CG2 REMARK 470 TYR C 249 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL C 250 CG1 CG2 REMARK 470 GLU C 251 CG CD OE1 OE2 REMARK 470 ASN C 253 CG OD1 ND2 REMARK 470 MET C 254 CG SD CE REMARK 470 LEU C 256 CG CD1 CD2 REMARK 470 ASN C 257 CG OD1 ND2 REMARK 470 PRO C 258 CG CD REMARK 470 SER C 259 OG REMARK 470 SER C 260 OG REMARK 470 PRO C 261 CG CD REMARK 470 ASN C 262 CG OD1 ND2 REMARK 470 LYS C 321 CG CD CE NZ REMARK 470 ARG C 334 CG CD NE CZ NH1 NH2 REMARK 470 HIS C 338 CG ND1 CD2 CE1 NE2 REMARK 470 GLU C 410 CG CD OE1 OE2 REMARK 470 LYS C 440 CG CD CE NZ REMARK 470 VAL D 242 CG1 CG2 REMARK 470 GLU D 243 CG CD OE1 OE2 REMARK 470 PRO D 244 CG CD REMARK 470 LYS D 245 CG CD CE NZ REMARK 470 THR D 246 OG1 CG2 REMARK 470 GLU D 247 CG CD OE1 OE2 REMARK 470 THR D 248 OG1 CG2 REMARK 470 TYR D 249 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL D 250 CG1 CG2 REMARK 470 GLU D 251 CG CD OE1 OE2 REMARK 470 ASN D 253 CG OD1 ND2 REMARK 470 MET D 254 CG SD CE REMARK 470 LEU D 256 CG CD1 CD2 REMARK 470 ASN D 257 CG OD1 ND2 REMARK 470 PRO D 258 CG CD REMARK 470 SER D 259 OG REMARK 470 SER D 260 OG REMARK 470 PRO D 261 CG CD REMARK 470 ASN D 262 CG OD1 ND2 REMARK 470 ASP D 263 CG OD1 OD2 REMARK 470 GLN D 270 CG CD OE1 NE2 REMARK 470 LYS D 274 CG CD CE NZ REMARK 470 HIS D 459 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 232 N LEU A 236 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 264 C - N - CA ANGL. DEV. = 10.1 DEGREES REMARK 500 HIS D 331 N - CA - C ANGL. DEV. = 16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 243 92.64 -60.53 REMARK 500 PRO A 244 105.93 -14.56 REMARK 500 LYS A 245 -144.22 -55.75 REMARK 500 ASN A 253 31.17 -82.56 REMARK 500 MET A 254 -57.04 -164.84 REMARK 500 LEU A 256 37.07 -78.47 REMARK 500 PRO A 258 -128.36 -68.09 REMARK 500 SER A 259 6.06 50.81 REMARK 500 SER A 260 104.76 26.52 REMARK 500 PRO A 261 35.88 -61.41 REMARK 500 ALA A 272 -61.05 67.15 REMARK 500 HIS A 288 -9.37 77.23 REMARK 500 LEU A 353 -73.37 -109.03 REMARK 500 ASN A 385 81.95 -153.84 REMARK 500 HIS A 435 30.30 -95.92 REMARK 500 LEU A 436 43.86 36.72 REMARK 500 GLU A 456 35.08 -153.23 REMARK 500 ALA A 457 -162.59 -60.88 REMARK 500 GLU B 243 76.01 159.42 REMARK 500 PRO B 244 -130.51 169.03 REMARK 500 LYS B 245 101.25 68.71 REMARK 500 THR B 246 -12.31 -41.02 REMARK 500 TYR B 249 13.53 -66.88 REMARK 500 GLU B 251 90.97 41.62 REMARK 500 ALA B 252 -175.27 -59.08 REMARK 500 ASN B 253 28.23 39.45 REMARK 500 MET B 254 -30.21 79.35 REMARK 500 SER B 259 -56.02 68.33 REMARK 500 SER B 260 97.86 50.06 REMARK 500 PRO B 261 121.63 -39.19 REMARK 500 ASN B 262 -64.98 -144.26 REMARK 500 PRO B 264 -104.09 -48.76 REMARK 500 HIS B 288 -12.78 73.46 REMARK 500 ASP B 322 -91.77 -158.29 REMARK 500 ASN B 385 79.63 -157.02 REMARK 500 GLN B 411 70.51 -115.75 REMARK 500 GLU C 243 144.01 -35.69 REMARK 500 PRO C 244 4.58 -46.76 REMARK 500 LYS C 245 -153.00 36.90 REMARK 500 ASN C 253 34.09 -74.02 REMARK 500 MET C 254 -76.44 -162.15 REMARK 500 LEU C 256 -0.08 -55.79 REMARK 500 PRO C 258 36.58 30.05 REMARK 500 SER C 259 -95.41 -93.24 REMARK 500 SER C 260 -20.47 67.26 REMARK 500 PRO C 261 127.35 71.77 REMARK 500 ASN C 262 -68.73 -137.79 REMARK 500 HIS C 288 -14.85 75.10 REMARK 500 ASP C 322 25.43 -149.40 REMARK 500 THR C 328 21.54 -78.40 REMARK 500 REMARK 500 THIS ENTRY HAS 66 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LBD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR REMARK 900 RECEPTOR RXR-ALPHA. NATURE 375 PP. 377 (1995) REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS REMARK 900 RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND REMARK 900 CO-ACTIVATOR PEPTIDES. REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS REMARK 900 RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO- REMARK 900 ACTIVATOR PEPTIDES. DBREF 1G1U A 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 1G1U B 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 1G1U C 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 1G1U D 225 462 UNP P19793 RXRA_HUMAN 225 462 SEQRES 1 A 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 A 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 A 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 A 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 A 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 A 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 A 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 A 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 A 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 A 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 A 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 A 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 A 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 A 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 A 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 A 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 A 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 A 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 A 238 HIS GLN MET THR SEQRES 1 B 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 B 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 B 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 B 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 B 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 B 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 B 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 B 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 B 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 B 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 B 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 B 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 B 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 B 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 B 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 B 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 B 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 B 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 B 238 HIS GLN MET THR SEQRES 1 C 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 C 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 C 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 C 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 C 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 C 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 C 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 C 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 C 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 C 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 C 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 C 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 C 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 C 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 C 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 C 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 C 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 C 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 C 238 HIS GLN MET THR SEQRES 1 D 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 D 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 D 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 D 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 D 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 D 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 D 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 D 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 D 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 D 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 D 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 D 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 D 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 D 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 D 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 D 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 D 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 D 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 D 238 HIS GLN MET THR FORMUL 5 HOH *310(H2 O) HELIX 1 1 THR A 246 ASN A 253 1 8 HELIX 2 2 ASP A 263 ILE A 286 1 24 HELIX 3 3 HIS A 288 LEU A 292 5 5 HELIX 4 4 PRO A 293 SER A 317 1 25 HELIX 5 5 ILE A 318 VAL A 320 5 3 HELIX 6 6 ARG A 334 GLY A 341 1 8 HELIX 7 7 VAL A 342 LEU A 353 1 12 HELIX 8 8 LEU A 353 MET A 360 1 8 HELIX 9 9 ASP A 363 PHE A 376 1 14 HELIX 10 10 ASN A 385 TYR A 408 1 24 HELIX 11 11 GLY A 413 LEU A 420 1 8 HELIX 12 12 ARG A 421 HIS A 435 1 15 HELIX 13 13 LEU A 436 GLY A 443 1 8 HELIX 14 14 ASP A 444 LEU A 455 1 12 HELIX 15 15 PRO B 231 VAL B 242 1 12 HELIX 16 16 ASP B 263 LYS B 284 1 22 HELIX 17 17 HIS B 288 LEU B 292 5 5 HELIX 18 18 PRO B 293 SER B 317 1 25 HELIX 19 19 ILE B 318 VAL B 320 5 3 HELIX 20 20 HIS B 333 ALA B 340 1 8 HELIX 21 21 VAL B 342 LEU B 353 1 12 HELIX 22 22 LEU B 353 GLN B 361 1 9 HELIX 23 23 ASP B 363 PHE B 376 1 14 HELIX 24 24 ASN B 385 TYR B 408 1 24 HELIX 25 25 GLY B 413 LEU B 420 1 8 HELIX 26 26 ARG B 421 HIS B 435 1 15 HELIX 27 27 LEU B 436 ALA B 457 1 22 HELIX 28 28 VAL C 232 VAL C 242 1 11 HELIX 29 29 THR C 246 ASN C 253 1 8 HELIX 30 30 ASP C 263 ILE C 286 1 24 HELIX 31 31 HIS C 288 LEU C 292 5 5 HELIX 32 32 PRO C 293 SER C 317 1 25 HELIX 33 33 ARG C 334 SER C 339 1 6 HELIX 34 34 VAL C 342 LEU C 353 1 12 HELIX 35 35 LEU C 353 MET C 360 1 8 HELIX 36 36 ASP C 363 PHE C 376 1 14 HELIX 37 37 ASN C 385 TYR C 408 1 24 HELIX 38 38 GLY C 413 LEU C 420 1 8 HELIX 39 39 ARG C 421 HIS C 435 1 15 HELIX 40 40 LEU C 436 ILE C 442 1 7 HELIX 41 41 GLY C 443 GLU C 456 1 14 HELIX 42 42 VAL D 232 ALA D 241 1 10 HELIX 43 43 THR D 246 GLY D 255 1 10 HELIX 44 44 VAL D 265 ARG D 285 1 21 HELIX 45 45 PRO D 293 SER D 317 1 25 HELIX 46 46 HIS D 333 ALA D 340 1 8 HELIX 47 47 VAL D 342 LEU D 353 1 12 HELIX 48 48 LEU D 353 MET D 360 1 8 HELIX 49 49 ASP D 363 PHE D 376 1 14 HELIX 50 50 ASN D 385 TYR D 408 1 24 HELIX 51 51 GLY D 413 LEU D 420 1 8 HELIX 52 52 ARG D 421 HIS D 435 1 15 HELIX 53 53 LEU D 436 GLY D 443 1 8 HELIX 54 54 ASP D 444 GLU D 456 1 13 SHEET 1 A 2 GLY A 323 LEU A 325 0 SHEET 2 A 2 HIS A 331 HIS A 333 -1 O VAL A 332 N ILE A 324 SHEET 1 B 2 ILE B 324 LEU B 325 0 SHEET 2 B 2 HIS B 331 VAL B 332 -1 N VAL B 332 O ILE B 324 SHEET 1 C 2 GLY C 323 LEU C 325 0 SHEET 2 C 2 HIS C 331 HIS C 333 -1 N VAL C 332 O ILE C 324 SSBOND 1 CYS A 269 CYS C 269 1555 1555 2.85 SSBOND 2 CYS B 269 CYS D 269 1555 1555 2.73 CRYST1 51.057 99.305 94.980 90.00 97.38 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019586 0.000000 0.002536 0.00000 SCALE2 0.000000 0.010070 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010616 0.00000